IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced ...

Backing from GV (Google Ventures), Iaso Ventures, and Virtue underscores ... commented: “Every day, biotech investors and business development professionals sift through huge amounts of data ...

Backing from GV (Google Ventures), Iaso Ventures, and Virtue underscores the industry’s recognition of Prudentia’s potential to disrupt the market. Anthony Philippakis, MD, PhD, General Partner at GV, ...

SHANGHAI and NANJING, China and SAN JOSE, Calif., Jan. 29, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing ...

Prime Minister Narendra Modi on Thursday released the genome sequencing data of 10,000 Indian nationals and said it will be a milestone in the field of biotechnology research. The Genome India ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Anticipation was in the air last January as biotechnology executives, analysts, and investors convened in San Francisco for the annual JPMorgan health care conference. After a couple of brutal ...

U.S.-based biotech builder Mountainfield Venture Partners and China’s Keymed Biosciences have launched a new company armed with $180 million in series A funds and a clinical-stage CD38-targeting ...

Prospective health secretary Robert F. Kennedy Jr. invested in biotechnology and had multiple sources of income in 2022 and 2023, financial disclosures show. The documents, which STAT obtained ...